InterVenn Biosciences Announces that Padmanee Sharma, MD, PhD, has Joined the Company’s Board of Advisors
b'InterVenn Biosciences today announced that Padmanee Sharma, MD, PhD, has joined the Company\xe2\x80\x99s Board of Advisors, effective March 9, 2021.
- b'InterVenn Biosciences today announced that Padmanee Sharma, MD, PhD, has joined the Company\xe2\x80\x99s Board of Advisors, effective March 9, 2021.
- Dr. Sharma joins the InterVenn Board of Advisors with extensive experience in basic and clinical immunology and cancer research.\nDr.
- and Jeanette Hsu Endowed Chair in Cell Biology in the Division of Cancer Medicine at MD Anderson Cancer Center.
- For more information about InterVenn Biosciences, please visit the company\xe2\x80\x99s website .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210415005368/en/\n'